Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Extrapancreatic autoantibody profiles in type I diabetes.

Burbelo PD, Lebovitz EE, Bren KE, Bayat A, Paviol S, Wenzlau JM, Barriga KJ, Rewers M, Harlan DM, Iadarola MJ.

PLoS One. 2012;7(9):e45216. doi: 10.1371/journal.pone.0045216. Epub 2012 Sep 21.

3.

Design and Measurement of Nonislet-Specific Autoantibodies for the Type 1 Diabetes Genetics Consortium Autoantibody Workshop.

Akolkar B, Hilner J, Nierras CR.

Diabetes Care. 2015 Oct;38 Suppl 2:S4-7. doi: 10.2337/dcs15-2002.

4.

Islet Autoantibodies.

Lampasona V, Liberati D.

Curr Diab Rep. 2016 Jun;16(6):53. doi: 10.1007/s11892-016-0738-2. Review.

PMID:
27112957
5.

Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes.

Brorsson CA, Pociot F; Type 1 Diabetes Genetics Consortium.

Diabetes Care. 2015 Oct;38 Suppl 2:S8-13. doi: 10.2337/dcs15-2003.

6.

Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.

Gan L, O'Hanlon TP, Gordon AS, Rider LG, Miller FW, Burbelo PD.

BMC Musculoskelet Disord. 2014 Mar 6;15:67. doi: 10.1186/1471-2474-15-67.

7.

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.

Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC.

Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5. Epub 2007 Oct 17.

8.

Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?

Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U.

Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):8-14.

PMID:
10707033
9.
11.

The cytokine production of peripheral blood mononuclear cells reflects the autoantibody profile of patients suffering from type 1 diabetes.

Labikova J, Vcelakova J, Ulmannova T, Petruzelkova L, Kolouskova S, Stechova K.

Cytokine. 2014 Oct;69(2):189-95. doi: 10.1016/j.cyto.2014.06.013. Epub 2014 Jul 1.

PMID:
24993165
12.

Emergence of anti-islet autoantibodies in Japanese patients with type 1 diabetes.

Horie I, Kawasaki E, Shimomura A, Satoh T, Ueki I, Kuwahara H, Ando T, Abiru N, Usa T, Eguchi K.

Endocr J. 2010;57(7):623-8. Epub 2010 May 25.

13.

Pancreatic islet autoimmunity.

Boitard C.

Presse Med. 2012 Dec;41(12 P 2):e636-50. doi: 10.1016/j.lpm.2012.10.003. Epub 2012 Nov 22. Review.

PMID:
23182678
14.

The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.

Andersson C, Larsson K, Vaziri-Sani F, Lynch K, Carlsson A, Cedervall E, Jönsson B, Neiderud J, Månsson M, Nilsson A, Lernmark A, Elding Larsson H, Ivarsson SA.

Autoimmunity. 2011 Aug;44(5):394-405. doi: 10.3109/08916934.2010.540604. Epub 2011 Jan 19.

PMID:
21244337
15.

Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.

Yu L, Liu Y, Miao D, Wenzlau J, Davidson H, Hutton J, Eisenbarth GS.

J Immunol Methods. 2010 Feb 28;353(1-2):20-3. doi: 10.1016/j.jim.2009.12.004. Epub 2009 Dec 24.

PMID:
20035758
16.

LIPS islet autoantibody assays in high-throughput format for DASP 2010.

Marcus P, Yan X, Bartley B, Hagopian W.

Diabetes Metab Res Rev. 2011 Nov;27(8):891-4. doi: 10.1002/dmrr.1268.

PMID:
22069280
17.

Development of a luciferase-based system for the detection of ZnT8 autoantibodies.

Ustinova J, Zusinaite E, Utt M, Metsküla K, Reimand K, Huchaiah V, Merits A, Uibo R.

J Immunol Methods. 2014 Mar;405:67-73. doi: 10.1016/j.jim.2014.01.009. Epub 2014 Jan 22.

PMID:
24462542
18.

Organ specific autoantibodies in preclinical and early clinical type 1 diabetes in Turkey.

Erten G, Gurol AO, Deniz G, Satman I, Yilmaz MT.

Ups J Med Sci. 2007;112(2):231-43.

PMID:
17578823
19.

Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.

Aanstoot HJ, Kang SM, Kim J, Lindsay LA, Roll U, Knip M, Atkinson M, Mose-Larsen P, Fey S, Ludvigsson J, Landin L, Bruining J, Maclaren N, Akerblom HK, Baekkeskov S.

J Clin Invest. 1996 Jun 15;97(12):2772-83.

20.

Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.

Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Böhm BO, Richter W.

Diabetes. 1997 Apr;46(4):565-71.

PMID:
9075795

Supplemental Content

Support Center